Case Report
Copyright ©The Author(s) 2021.
World J Clin Cases. Oct 26, 2021; 9(30): 9144-9150
Published online Oct 26, 2021. doi: 10.12998/wjcc.v9.i30.9144
Figure 1
Figure 1 Pathological microscopic image with hematoxylin-eosin staining of lymph node biopsy in case once (A) and of marrow biopsy in case two (B).
Figure 2
Figure 2 Flow cytometric analysis showed two separate populations of cells the red one positive for myeloblast markers (CD117, CD34, CD33, CD13, HLADR, CD38, MPO) and the green one for B lymphoid markers [CD19, CD5, CD22, CD20, CD23(weak), CD200, kappa light chain] in case one (A), and two separate populations of cells the red one positive for myeloblast markers (CD117, CD34, CD33, CD13, HLA-DR, CD38) and the green one for B lymphoid markers [CD19, CD5, CD22 (weak), CD20 (weak), CD23, CD200, Kappa light chain] in case two (B).